VanEck Israel ETF (ISRA)

A country ETF is a fund that holds the publicly traded equity securities of companies domiciled in and headquartered in a single nation. The VanEck Israel ETF (ISRA) focuses exclusively on Israeli-listed companies and aims to track a broad index of that market — offering investors concentrated exposure to one country’s economic growth and innovation.

From refuge to high-tech hub

Israel’s economy was built on necessity. After the state’s founding in 1948, it faced immediate existential pressures that forced rapid industrialisation, which led to strong technical education and a culture of problem-solving through engineering. The early decades focused on agriculture and light manufacturing, but by the 1980s and 1990s, a cluster of software and technology companies began to grow. By the early 2000s, Israel had become a genuine innovation hub, producing disproportionate numbers of semiconductor designers, biotech companies, and digital security firms despite having a population smaller than New York City.

VanEck launched the Israel ETF in the early 2000s to capture this tech-heavy growth story. At that time, Israeli equities were difficult for Western retail investors to access directly; the fund opened a door to the Tel Aviv Stock Exchange without the friction of international brokerage accounts. The fund’s popularity has waxed and waned with Israeli macroeconomic conditions, geopolitical risk, and the global appetite for emerging-market technology exposure.

What ISRA holds and how sectors align

ISRA tracks the BlueStar Israel Global Index, which includes companies listed on the Tel Aviv Stock Exchange and traded in U.S. dollars on international exchanges. The 81 holdings span pharmaceuticals, technology, semiconductors, financial services, and telecommunications, with a heavy concentration in the sectors where Israeli innovation is strongest.

The largest holdings are typically pharmaceutical and biotech firms (Teva Pharmaceutical Industries, Compugen), major banks (Bank Leumi, Bank Hapoalim), semiconductor and defense contractors (Elbit Systems), and cybersecurity companies (Check Point Software). This composition reflects Israel’s real economic strengths — a deep bench in life sciences and digital security, plus necessity-driven financial institutions that serve a capital-intensive, security-focused nation.

Holdings are large by Israeli standards. Israel’s equity market is far smaller than most developed markets, so even “large-cap” Israeli stocks trade at volumes that Western investors often find thin. ISRA solves this by holding the most liquid instruments available, but trading ISRA itself can be wide-spread during off-hours because the fund’s underlying constituents do not trade continuously when U.S. markets are open.

Risks and concentrations

Country-specific funds carry structural risks that diversified global funds avoid. A fund holding only Israeli securities is exposed entirely to Israeli macroeconomic policy, currency fluctuations (the fund’s assets are in Israeli shekels, converted to USD for U.S. trading), and geopolitical events unique to the region. The Israeli shekel moves sharply at times of heightened regional tension, which can swing the fund’s returns independent of the underlying stock performance.

ISRA is also smaller than mainstream broad-market ETFs, which means it trades with tighter asset bases. During stress, liquidity can evaporate faster than in mega-cap index funds. The fund’s holdings skew heavily toward a small number of mega-cap Israeli companies, so ISRA is not as diversified as it appears — the top 10 holdings represent a large fraction of the fund’s value, concentrating idiosyncratic risk in a handful of firms.

Additionally, Israeli companies are disproportionately exposed to export-dependent sectors like semiconductors and pharmaceuticals. These industries’ valuations move on global technology and biotech trends, not solely on Israeli economic health, which can create disconnects between what Israeli equity indices do and what global tech markets do.

How to research ISRA

Start with the BlueStar Israel Global Index methodology, published by the index provider, which defines exactly which securities qualify and how they are weighted. VanEck’s fact sheet lists the current top holdings and sector allocations. Because the fund is small and Israeli equities are unfamiliar to many Western investors, read a few recent equity research reports on major Israeli tech or biotech companies to understand the kind of business risk you are taking on. Track the Israeli shekel’s exchange rate versus the U.S. dollar, since that currency movement flows directly through to returns. Finally, compare ISRA’s price to its net asset value daily, particularly before or after major news events in Israel, because the mismatch can widen significantly — sometimes offering a buying opportunity or a reason to exit before the market reprices.